vs
Ares Commercial Real Estate Corp（ACRE）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Ares Commercial Real Estate Corp的1.5倍（$19.6M vs $13.2M），Ares Commercial Real Estate Corp净利率更高（-29.2% vs -177.4%，领先148.2%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -24.5%），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -15.9%）
Ares Commercial Real Estate Corp是隶属于阿瑞斯管理集团的专业金融企业，专注于商业地产领域，提供优先抵押贷款、次级债务、优先股投资等各类定制化融资解决方案，主要服务覆盖美国全境的中型商业地产所有者及运营主体。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ACRE vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.2M | $19.6M |
| 净利润 | $-3.9M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | -29.2% | -168.5% |
| 净利率 | -29.2% | -177.4% |
| 营收同比 | -24.5% | -11.5% |
| 净利润同比 | 63.8% | -28.8% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $13.2M | — | ||
| Q3 25 | $14.1M | $19.6M | ||
| Q2 25 | $12.6M | $21.8M | ||
| Q1 25 | $14.9M | $40.8M | ||
| Q4 24 | $17.5M | — | ||
| Q3 24 | $16.7M | $22.1M | ||
| Q2 24 | $16.8M | $22.5M | ||
| Q1 24 | $18.7M | $45.5M |
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $4.7M | $-34.7M | ||
| Q2 25 | $-11.0M | $-33.5M | ||
| Q1 25 | $9.3M | $-26.0M | ||
| Q4 24 | $-10.7M | — | ||
| Q3 24 | $-5.9M | $-26.9M | ||
| Q2 24 | $-6.1M | $-45.7M | ||
| Q1 24 | $-12.3M | $-32.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
| Q4 25 | -29.2% | — | ||
| Q3 25 | 33.0% | -168.5% | ||
| Q2 25 | -87.8% | -118.1% | ||
| Q1 25 | 64.4% | -80.8% | ||
| Q4 24 | -61.0% | — | ||
| Q3 24 | -35.3% | -120.9% | ||
| Q2 24 | -36.5% | -134.5% | ||
| Q1 24 | -65.9% | -132.2% |
| Q4 25 | -29.2% | — | ||
| Q3 25 | 33.0% | -177.4% | ||
| Q2 25 | -87.8% | -153.7% | ||
| Q1 25 | 62.5% | -63.8% | ||
| Q4 24 | -60.9% | — | ||
| Q3 24 | -35.3% | -122.0% | ||
| Q2 24 | -36.5% | -203.3% | ||
| Q1 24 | -65.9% | -70.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.3M | $129.4M |
| 总债务越低越好 | $948.2M | — |
| 股东权益账面价值 | $509.6M | $399.7M |
| 总资产 | $1.6B | $539.6M |
| 负债/权益比越低杠杆越低 | 1.86× | — |
8季度趋势，按日历期对齐
| Q4 25 | $29.3M | — | ||
| Q3 25 | $84.9M | $129.4M | ||
| Q2 25 | $90.0M | $158.6M | ||
| Q1 25 | $125.5M | $150.9M | ||
| Q4 24 | $63.8M | — | ||
| Q3 24 | $68.9M | $210.6M | ||
| Q2 24 | $70.6M | $269.8M | ||
| Q1 24 | $99.5M | $287.1M |
| Q4 25 | $948.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $718.5M | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
| Q4 25 | $509.6M | — | ||
| Q3 25 | $521.0M | $399.7M | ||
| Q2 25 | $523.7M | $424.5M | ||
| Q1 25 | $542.1M | $454.6M | ||
| Q4 24 | $540.1M | — | ||
| Q3 24 | $563.8M | $489.3M | ||
| Q2 24 | $582.3M | $510.3M | ||
| Q1 24 | $601.1M | $577.3M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.4B | $539.6M | ||
| Q2 25 | $1.4B | $557.0M | ||
| Q1 25 | $1.5B | $579.6M | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.9B | $681.5M | ||
| Q2 24 | $2.1B | $708.7M | ||
| Q1 24 | $2.1B | $777.7M |
| Q4 25 | 1.86× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.4M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $21.4M | — | ||
| Q3 25 | $3.8M | $-22.2M | ||
| Q2 25 | $4.9M | $-20.7M | ||
| Q1 25 | $8.0M | $-30.3M | ||
| Q4 24 | $35.5M | — | ||
| Q3 24 | $8.4M | $-27.9M | ||
| Q2 24 | $8.7M | $-39.0M | ||
| Q1 24 | $11.4M | $-62.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | 0.82× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACRE
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
